跳至主要内容
临床试验/NCT06398145
NCT06398145尚未招募2 期

The Use of D-chiro-inositol in the Treatment of AUB

University Of Perugia0 个研究点目标入组 20 人开始时间: 2024年6月1日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
20
主要终点
AUB

研究概览

简要总结

Patients with AUB will undergo 6-month treatment with D-chiro-inositol and will fill in questionnaires on AUB, with the evaluation of hormonal serum levels.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Menopause
  • Cancer diagnosis
  • Atypical endometrial hyperplasia
  • Uterine fibroids
  • Heavy symptoms requiring pharmacological intervention
  • Progestogens treatment in the six months before the study
  • Inositol treatment in the six months before the study

结局指标

主要结局

AUB

时间窗: 0, 3 and 6 months

The "Menstrual Bleeding Questionnaire", a standardized and validated questionnaire, will be administered to patients to evaluate te extent of AUB and the impact on their quality of life.

次要结局

  • Serum level of Testosterone(0, 3 and 6 months)
  • Serum level of High-Density Lipoprotein(0, 3 and 6 months)
  • Serum level of Low-Density Lipoprotein(0, 3 and 6 months)
  • Serum level of Total cholesterol(0, 3 and 6 months)
  • Serum level of Estradiol(0, 3 and 6 months)
  • Serum level of Estrone(0, 3 and 6 months)
  • Serum level of Androstenedione(0, 3 and 6 months)
  • Serum level of Triglyceride(0, 3 and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sandro Gerli

Professor

University Of Perugia

相似试验